TGFB1 and myeloproliferative neoplasm: Next, we treated the model cell lines with interferon-γ (IFNγ), tumor necrosis factor-alpha (TNFα), and transforming growth factor-beta 1 (TGFβ1), the upstream principal regulators of the inflammatory program and microenvironment alterations in MPN [15–17].